Insulin-like growth factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies by Simpson, A, Petnga, W, Macaulay, V, Weyer-Czernilofsky, U, Bogenrieder, T

Bad to the bone: The role of the insulin-like growth factor axis in osseous metastasis by Rieunier, G, Wu, X, Macaulay, V, Lee, A, Weyer-Czernilofsky, U, Bogenrieder, T

CHK1 inhibition exacerbates replication stress induced by IGF blockade by Wu, X, Seraia, E, Hatch, SB, Wan, X, Ebner, DV, Aroldi, F, Jiang, Y, Ryan, AJ, Bogenrieder, T, Weyer-Czernilofsky, U, Rieunier, G, Macaulay, VM

Targeting IGF perturbs global replication through ribonucleotide reductase dysfunction by Rieunier, G, Wu, X, Harris, LE, Mills, JV, Nandakumar, A, Colling, L, Seraia, E, Hatch, SB, Ebner, DV, Folkes, LK, Weyer-Czernilofsky, U, Bogenrieder, T, Ryan, AJ, Macaulay, VM

Nuclear IGF1R interacts with regulatory regions of chromatin to promote RNA Polymerase II recruitment and gene expression associated with advanced tumor stage by Aleksic, T, Gray, N, Wu, X, Rieunier, G, Osher, E, Mills, J, Verrill, C, Bryant, R, Han, C, Hutchinson, K, Lambert, A, Kumar, R, Hamdy, F, Weyer-Czernilofsky, U, Sanderson, M, Bogenrieder, T, Taylor, S, Macaulay, V